Clinical and pathologic relevance of p53 index in canine osseous tumors
- PMID: 12724563
- DOI: 10.1354/vp.40-3-237
Clinical and pathologic relevance of p53 index in canine osseous tumors
Abstract
The clinicopathologic value of the immunohistochemical (IHC) expression of p53 protein was evaluated in 167 canine osseous tumors. p53 staining frequency and intensity in tumor cells was expressed as a p53 index. p53 index was significantly higher in osteosarcomas than in other sarcomas, chondrosarcoma, multilobular tumor of bone, and tumors initially misdiagnosed as osteosarcomas as well as in appendicular versus axial and in distal versus proximal osteosarcomas. A strong correlation is demonstrated between the p53 index and a range of clinicopathologic parameters in osteosarcoma, including the tumor site, histologic grade and score, mitotic index, degree of tumor necrosis, and pleomorphism. Chondroblastic osteosarcomas had significantly higher and telangiectatic osteosarcomas significantly lower p53 index than did osteosarcomas belonging to other histopathologic subtypes, a fact that tends to reinforce the perception of these osteosarcomas as distinct clinicopathologic entities. Entire males had higher p53 index than did neutered males. p53 index was higher in Rottweilers than in Great Danes and Terriers, confirming breed susceptibilities to osteosarcoma. p53 index showed no association with age, primary or secondary site status, or the presence of metastases or other tumor types. Biopsy samples had a higher p53 index than did postmortem samples, either because of differences in sample processing or the possibility that p53 overexpression is more evident at the earlier stages of osteosarcoma pathogenesis, presumably represented by the biopsy material. IHC examination for p53 and the derived index has the potential to be used as an additional diagnostic tool and prognostic indicator for osseous tumors.
Similar articles
-
Clinicopathological relevance of tumour grading in canine osteosarcoma.J Comp Pathol. 2007 Jan;136(1):65-73. doi: 10.1016/j.jcpa.2006.11.005. Epub 2007 Jan 30. J Comp Pathol. 2007. PMID: 17270206
-
p53 tumor suppressor protein overexpression in osteogenic tumors of dogs.Vet Pathol. 1996 Mar;33(2):213-21. doi: 10.1177/030098589603300211. Vet Pathol. 1996. PMID: 8801715
-
Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.Vet Pathol. 2013 Jul;50(4):704-8. doi: 10.1177/0300985812471542. Epub 2012 Dec 26. Vet Pathol. 2013. PMID: 23269349
-
Comparative biology of human and canine osteosarcoma.Anticancer Res. 2007 Jan-Feb;27(1A):155-64. Anticancer Res. 2007. PMID: 17352227 Review.
-
Osteogenic sarcomas of the hands: A case series with emphasis in its peculiarities and literature review.Pathol Res Pract. 2023 Feb;242:154326. doi: 10.1016/j.prp.2023.154326. Epub 2023 Jan 20. Pathol Res Pract. 2023. PMID: 36716613 Review.
Cited by
-
Studying the DNA damage response pathway in hematopoietic canine cancer cell lines, a necessary step for finding targets to generate new therapies to treat cancer in dogs.Front Vet Sci. 2023 Aug 16;10:1227683. doi: 10.3389/fvets.2023.1227683. eCollection 2023. Front Vet Sci. 2023. PMID: 37655260 Free PMC article.
-
Risk factors for appendicular osteosarcoma occurrence in large and giant breed dogs in western Canada.Can Vet J. 2023 Feb;64(2):167-173. Can Vet J. 2023. PMID: 36733647 Free PMC article.
-
Comprehensive live-cell imaging analysis of cryptotanshinone and synergistic drug-screening effects in various human and canine cancer cell lines.PLoS One. 2021 Feb 5;16(2):e0236074. doi: 10.1371/journal.pone.0236074. eCollection 2021. PLoS One. 2021. PMID: 33544704 Free PMC article.
-
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.J Vet Diagn Invest. 2021 Mar;33(2):261-278. doi: 10.1177/1040638720985242. Epub 2021 Jan 15. J Vet Diagn Invest. 2021. PMID: 33446089 Free PMC article.
-
Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology.Front Oncol. 2019 Nov 22;9:1291. doi: 10.3389/fonc.2019.01291. eCollection 2019. Front Oncol. 2019. PMID: 31824863 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
